RANDOMIZED PHASE-II TRIAL OF CARMINOMYCIN VERSUS 4'-EPIDOXORUBICIN IN ADVANCED BREAST-CANCER

被引：26

作者：

ROZENCWEIG, M

HUININK, WT

CAVALLI, F

BRUNTSCH, U

DOMBERNOWSKY, P

HOST, H

BRAMWELL, V

RENARD, G

VANGLABBEKE, M

DECOSTER, G

CLARYSSE, A

机构：

[1] INST JULES BORDET,B-1000 BRUSSELS,BELGIUM

[2] NETHERLANDS CANC INST,1066 CX AMSTERDAM,NETHERLANDS

[3] OSPED SAN GIOVANNI,BELLINZONA,SWITZERLAND

[4] MED KLIN 5 NURNBERG,NURNBERG,FED REP GER

[5] UNIV COPENHAGEN HOSP,DK-2100 COPENHAGEN,DENMARK

[6] DET NORSKE RADIUMHOSP,OSLO,NORWAY

[7] CHRISTIE HOSP & HOLT RADIUM INST,MANCHESTER M20 9BX,LANCS,ENGLAND

[8] EUROPEAN ORG RES & TREATMENT CANC,CTR DATA,BRUSSELS,BELGIUM

[9] ALGEMEEN ZIEKENHUIS ST JAN,BRUGGE,BELGIUM

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1984年 / 2卷 / 04期

关键词：

D O I：

10.1200/JCO.1984.2.4.275

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：275 / 281

页数：7

共 25 条

[1] CARMINOMYCIN (NSC-180024) - A PHASE-I STUDY [J].

ABELE, R ;

ROZENCWEIG, M ;

BODY, JJ ;

BEDOGNI, P ;

REICH, SD ;

CROOKE, ST ;

LENAZ, L ;

KENIS, Y .

EUROPEAN JOURNAL OF CANCER, 1980, 16 (12) :1555-1559

[2]

AHMANN DL, 1973, CANCER RES, V33, P1707

[3]

[Anonymous], 1979, WHO HDB REPORTING RE

[4]

BAKER LH, 1979, CANCER TREAT REP, V63, P899

[5]

BENEDETTO P, 1982, P AM ASS CLIN ONCOL, V1, P114

[6]

BONFANTE V, 1980, RECENT RES CANCER, V74, P192

[7]

Carter S K, 1974, Semin Oncol, V1, P131

[8]

CASAZZA AM, 1979, CANCER TREAT REP, V63, P835

[9]

CASAZZA AM, 1978, CURRENT CHEMOTHERAPY, P1257

[10]

COMIS RL, 1982, CANCER RES, V42, P2944

← 1 2 3 →